Introduction
Resistance of cancer cells to chemo-and radiotherapy is a vital medical problem that is frequently caused by dysregulation of the cell death and survival program (Igney and Krammer, 2002; Pommier et al., 2004; Brown and Attardi, 2005) . During the last few decades, different genes have been identified that govern the tight regulation of the complex network of life and death. Two major pathways can lead to apoptosis, the intrinsic (mitochondrial) and the extrinsic pathway that initiate the proteolytic cascade of caspases and thus apoptosis (Ashkenazi and Dixit, 1998; Green and Reed, 1998; Reed, 2001) . Several stimuli, such as growth factor deprivation, generation of reactive oxygen species (ROS) or application of DNA-damaging agents (e.g. doxorubicin) initiate the intrinsic pathway. Mitochondrial cytochrome c release and apoptosome assembly mediates activation of the effector caspase-3 and cell death. Permeabilization of the mitochondrial membrane and cytochrome c release is mediated by members of the proapoptotic protein family (e.g. Bax, Bak) that oligomerize and insert into the outer mitochondrial membrane. Antiapoptotic proteins (e.g. Bcl-2, Bcl-X L ) reside in the outer mitochondrial membrane and block cytochrome c release (Riedl and Shi, 2004) . However, cells have developed various strategies to block apoptosis at the late stages of the pathway. Cell survival can be mediated through inhibitors of apoptosis (IAPs), which inactivate caspase-3, -7 and -9 (Schimmer, 2004) . Proapoptotic proteins can be sequestered by 14-3-3 (Nomura et al., 2003) and heat-shock proteins (HSPs) have the capability to inhibit apoptosome proteins (Beere, 2004) . The extrinsic pathway is mediated via death receptors, which belong to the tumor necrosis factor (TNF) receptor family. Ligand binding mediates receptor trimerization and recruitment of intracellular proteins, which form the death-inducing signaling complex (DISC) and triggers caspase-8 activation that in turn initiates proteolytic activation of caspase-3 and caspase-7. Cleaved Bid connects the extrinsic with the mitochondrial pathway (Ashkenazi and Dixit, 1998) . The extrinsic pathway is also inhibitable at different levels. For example, FLICE inhibitory protein (FLIP) interferes with the recruitment of the caspase-8 to DISC and nuclear factor kappaB (NFkB) can act as a survival factor through IAPs and FLIP upregulation (LaCasse et al., 1998; Kreuz et al., 2004) .
Osteopontin (OPN) is a glycoprotein that is secreted by various cell types including mammary gland epithelial cells (ME-cells). OPN has been associated with breast cancer progression, metastasis and apoptosis Khan et al., 2002; Wai and Kuo, 2004) . OPN mediates cell-matrix interactions and cellular signaling through integrin-and CD44-receptors (Hu et al., 1995; Weber et al., 1996; Furger et al., 2001) . Ligand binding activates several downstream kinases including focal adhesion kinase (FAK,) mitogen-activated protein kinase (MAPK)/ extracellular signal-regulated kinase (ERK) kinase (MEK)1/2 and phosphatidylinositol 3-kinase (PIK3)/ Akt (Lin and Yang-Yen, 2001; Mitra et al., 2005) . Akt phosphorylates serine (Ser) 196 and ERK1/2 threonine (Thr) 125 of the caspase-9 and inhibits caspase-3 activation (Fujita et al., 1999; Allan et al., 2003) . In rodents, which lack the Akt phosphorylation site at caspase-9 (Fujita et al., 1999) , the MEK1/2 inhibitor (PD98059) restored caspase-3 activity and cell death (Erhardt et al., 1999) .
To study tumorigenesis, apoptosis and cell survival, we generated different transgenic animals (e.g. WAP-SVT/t) that synthesize the SV40 T/t-antigen in ME-cells. All WAP-SVT/t females develop breast cancer after the first pregnancy. A further feature of these animals is an elevated ME-cell apoptosis rate, which starts during late pregnancy, and is maintained in breast tumors and in corresponding tissue culture cell lines (Tzeng et al., 1993 (Tzeng et al., , 1998 . Furthermore, breast tumor cells (e.g. ME-A cells) are sensitive to apoptotic stimuli such as ultraviolet (UV)-irradiation, oxidative stress and the DNA-damaging agents etoposide and doxorubicin (Tzeng et al., 1998; Kohlhoff et al., 2000) . However, breast tumors frequently contain cells that are very resistant to apoptosis-inducing agents. All of the apoptosis resistant WAP-SVT/t tumor cells we have analysed so far (e.g. ME-C cells) carry a p53 missense mutation at codon 242, that is also frequently found in human breast cancer cells (mouse p53 codon 242 corresponds to human p53 codon 245) or were obtained from WAP-SVT/t:p53 À/À animals (Tzeng et al., 1998) . In this investigation, we demonstrate that ME-C cells secrete a soluble antiapoptotic factor(s), which efficiently inhibits apoptosis. Microarray as well as Western blot analysis revealed that OPN is overexpressed and about 1000-fold more efficiently secreted by the ME-C cells than by the ME-A cells. Induction of ME-A cell apoptosis by serum starvation or doxorubicin could be efficiently inhibited by addition of the OPN containing ME-C cell medium, without preventing mitochondrial cytochrome c release. Growth factor withdrawal as well as doxorubicin treatment induces ME-A cell apoptosis via the c-Jun N-terminal kinase (JNK) cascade that is inhibited by dicoumarol. However, the OPN-containing ME-C cell medium mediates inhibition of cell death through MEK1/2, but it does not prevent caspase-9 processing. In the case of growth factor withdrawal, it causes caspase-3 inhibition and for doxorubicin an unidentified factor(s) downstream of caspase-3 is the final target.
Results and discussion
ME-A and ME-C cells are immortalized breast cancer cells derived from the WAP-SVT/t tumor 8/61 (transgenic animal WAP-SVT/t line 8, female 61) (Tzeng et al., 1993) . Under standard tissue culture conditions (Dulbecco's modified Eagle's medium (DMEM) þ 5% fetal calf serum (FCS)), the ME-A cells exhibit an elevated spontaneous apoptosis rate of 2-5% ( Figure 1A ). Furthermore, ME-A cells are very sensitive to growth factor depletion and DNA-damaging agents such as doxorubicin or etoposide. After serum withdrawal for 22 h, about 30% of the ME-A cells are apoptotic (Figure 1c) , and 22 h after addition of doxorubicin (1 mM) to the cells under standard culture conditions, a large number of the ME-A cells exhibited caspase-dependent morphological alterations such as chromatin condensation, nucleus fragmentation, apoptotic bodies (Figure 1g , insert) and further apoptotic hallmarks such as oligonucleosomal DNA fragmentation (Tzeng et al., 1998) . In contrast to the ME-A cells, ME-C cells, which carry a p53 missense mutation (p53 242 : GGC to GCC), exhibit a low spontaneous cell death rate and the cells are very insensitive to apoptotic stimuli ( Figure 1k ). On co-cultivation of the two breast tumor cell types, we observed that the ME-C cells suppress ME-A cell apoptosis. This indicates that the ME-C cells secrete an antiapoptotic compound that acts as a cell death inhibitor.
To characterize the secreted antiapoptotic factor, ME-C cell culture medium was collected after a 2-day serum starvation period, dialysed and concentrated to a final protein concentration of 1 mg/ml phosphatebuffered saline (PBS) (termed medium concentrate (MC)). Different amounts of the MC were added to the ME-A cell medium without serum for 22 h and the apoptosis rate was determined by fluorescence microscopy (propidium iodide staining). As shown in Figure 2a , 2 mg/ml strongly reduced the ME-A cell apoptosis rate and 20 mg/ml entirely blocked the growth factor depletion induced apoptosis (Figures 1e and 2a) . In the following experiments, the MC was applied at a final concentration of 20 mg/ml.
When doxorubicin (1 mM) was added for 22 h together with the MC, the doxorubicin-induced ME-A cell apoptosis rate was reduced to 2-5%, as shown by fluorescence microscopy (Figure 1i ). Similar results were obtained when ME-A cell apoptosis was determined by TdT-mediated dNTP nick-end labeling (TUNEL), Annexin-V or by FACScan analysis (data not shown). Pre-heating (20 min, 601C) entirely abolished the antiapoptotic activity of MC, indicating that the death inhibitor is a protein/glycoprotein. The molecular weight of the active factor must be larger than 14 kDa, which was the dialysis cutoff size.
We also prepared MCs from ME-A cells under standard and serum starvation conditions, but these concentrates failed to inhibit ME-A cell apoptosis and did not cause ME-C cell apoptosis, indicating that the ME-A cells do not secrete an apoptosis-inducing factor (data not shown).
OPN is the most abundant glycoprotein secreted by the ME-C cells To identify the potential apoptosis inhibitor(s), the gene expression profile of ME-A cells and ME-C cells was determined by microarray and reverse transcriptionpolymerase chain reaction (RT-PCR) analysis. Focusing on secreted proteins we identified 48 genes that are either selectively overexpressed in ME-C cells by a factor of at least two, or which were absent in the ME-A cells (Supplement 1). Among them, OPN exhibited the highest expression level, being about threefold overexpressed in ME-C cells versus the ME-A cells (Supplement 1)
To verify that the ME-C cells efficiently secrete OPN, the MC was subjected to Western blot analysis (200 ng total protein). Using a mouse monoclonal antibody, different OPN-specific isoforms were found to be efficiently secreted by the ME-C cells but not by the ME-A cells ( Figure 3a) . As deduced from the nucleotide sequence, the mouse OPN gene encodes a 294-aminoacid protein. Therefore, the lowest molecular isoform (Figure 3a ) could be the primary translation product. As OPN is highly glycosylated (N-and O-glycans) and phosphorylated (Denhardt and Guo, 1993; Shanmugam et al., 1997; Christensen et al., 2005) , the slower migrating isoforms (37-115 kDa) should represent post-translational OPN modifications. In contrast, the ME-C cell lysate contained only two OPN isoforms (56 and 58 kDa), which are more abundant after growth factor withdrawal (Figure 3b ). This indicates that OPN secretion is a rapid event and that extensive OPN modifications may occur at the extracellular level, a topic not further addressed in this investigation.
To prove whether the ME-A cells actually secrete OPN, 20 mg of the ME-A cell MC were subjected to Western blot analysis. Under these conditions, secretion of two OPN isoforms (40-42 kDa) was detectable 22 h after serum depletion but not when the ME-A cells were kept under standard tissue culture conditions (Figure 3c ). This demonstrates that OPN is also a stress response protein in the ME-A cells. Densitometry measurements revealed that the amount of OPN secreted by the ME-C cells is about 500-1000-fold higher than that of the ME-A cells. The fact that the difference of the OPN gene expression level is only threefold indicates that in the ME-A cells, the OPN mRNA is either less efficiently translated or OPN has lower half-life, a question not further addressed in this investigation.
To narrow down the size of the apoptosis inhibitor(s), the ME-C cell MC was subjected to Superdex G200 column chromatography and each fraction was tested Figure 1 ME-A and ME-C cell apoptosis. (A) Fluorescence microscopy of ME-A and ME-C cells after staining with propidium iodide for 10 min (Zeiss, Axioskop; magnification Â 100) and (B) phase-contrast microscopy of the cells shown in (A). (a) and (b) ME-A cells cultivated under standard conditions (DMEM with 5% FCS); (c) and (d) ME-A cells cultivated for 22 h in serum-free medium (0% FCS in DMEM; (e) and (f) ME-A cells cultivated for 22 h in serum-free medium in the presence of MC (20 mg/ml); (g) and (h) ME-A cells cultivated in DMEM with 5% FCS for 22 h in the presence of 1 mM doxorubicin. Insert: Apoptotic cells at magnification Â 250; (i) and (j) ME-A cells cultivated for 22 h in the presence of doxorubicin and MC; (k) and (l) ME-C cells cultivated under standard conditions for 22 h in the presence of 1 mM doxorubicin.
for the antiapoptotic activity. These experiments revealed that the fraction enriched for proteins with a molecular weight of about 20-40 kDa was the most active one, having a threefold higher antiapoptotic activity than the MC. The higher molecular fractions (>50 kDa) did not contain any antiapoptotic activity (data not shown).
The ME-C cell MC was also subjected to twodimensional (2D) electrophoresis. One gel was used for silver staining (Figure 3d ) and the second for immunoblotting ( Figure 3e ). These experiments confirmed that OPN represents the major fraction in the ME-C cell MC. The protein pattern was further compared with that of the ME-A cell MC in the 20-40 kDa gel region. This analysis revealed that OPN is the main protein ( Figure 3f , large arrow) and that this gel region contains several additional, less abundant unidentified proteins (small arrows) which are absent in the ME-A cell MC ( Figure 3g ). Therefore, it is tempting to speculate that one of the lower molecular weight OPN isoform(s) is the major antiapoptotic factor of the ME-C cell MC.
To verify this, the OPN content of the ME-C cell MC was lowered by four successive immunoprecipitations, utilizing the mouse monoclonal OPN antibody ( Figure 2b ; similar results were obtained with the polyclonal goat OPN antibody, data not shown). Starting with a total protein concentration of 5 mg/ml, about 70% of the OPN was eliminated from the ME-C cell MC. The immunoprecipitation was selective for OPN, as the quantity of other proteins secreted by the ME-C cells, such as connective tissue growth factor (CTGF) Supplement 1), remained unchanged in the MC as is shown in Figure 2c . The OPN depleted ME-C cell concentrate was then added together with serum-free medium to the ME-A cells and the apoptosis rate was about 15% after 22 h ( Figure 2d ). This is in accordance with the results obtained with the dilution experiments of the ME-C cell MC (Figure 2a ). Therefore, we consider OPN as the main antiapoptotic factor secreted by the ME-C cells.
MC does not block mitochondrial cytochrome c release
Cytochrome c release from the mitochondria is a key regulatory step of the intrinsic apoptosis pathway. In the presence of ATP/dATP, cytochrome c together with Apaf-1 and caspase-9 generates the apoptosomes that ultimately activate the effector caspase-3 (Jiang and Wang, 2004) . Western blot analysis revealed that under standard culture conditions, cytochrome c is released from the mitochondria into the cytoplasm of the ME-A cells and is slightly increased in the absence of serum (Figure 4a ). In contrast, the inner membrane protein cytochrome c oxidase III was totally absent in the cytosol, confirming the purity of the fractions (Figure 4g ). To test whether MC prevents cytochrome c release, it was added to ME-A cells for 22 h under serum starvation conditions. Although apoptosis was inhibited, cytochrome c release was augmented (Figure 4a ). Similar results were obtained, when ME-A cell apoptosis was induced by doxorubicin (data not shown). . The blot was hybridized with goat polyclonal anti-CTGF (Santa Cruz, sc-14939). (d) OPN depletion lowers the antiapoptotic activity of MC ME-A cell apoptosis rate as % (1) ME-A cells cultivated under standard culture conditions; (2) in medium without serum; (3) in medium without serum plus MC (5 mg/ml); and (4) in medium without serum plus OPN-depleted MC (supernatant after the fourth immunoprecipitation). Numbers given are mean values of three independent experiments. Cells were stained with propidium iodide for 10 min and apoptotic cells were counted by fluorescence microscopy.
Serum starvation as well as doxorubicin causes activation of the JNK signaling pathway At present it is not clear how the MC inhibits apoptosis. The fact that it does not block cytochrome c release indicates that inhibition occurs downstream from the mitochondria. This is in accordance with our microarray data (Supplement 1) and Western blot results, showing that MC does not change the expression profile of the known pro-or antiapoptotic genes (e.g. Bax, Bak, Bcl-2, Bcl-X L ). In healthy cells, the monomeric Bax is the dominant cytosolic form that following death stimulation translocates to the outer mitochondrial membrane, forming multimeric complexes. Mitochondria lose their membrane potential (Dc m ) and intermembrane proteins are released (Nechushtan et al., 2001) . As shown in Figure 4c , the Bax monomer (23 kDa, which runs in our experimental gel conditions at about 18 kDa) is present at similar levels in both the cytoplasmic as well as the mitochondrial fraction. The higher molecular weight form (43 kDa), which presumably represents a homo-or hetero-oligomer, is dominant in the mitochondrial fraction and is slightly reduced by dicoumarol treatment but not by MC. The mitochondrial lysate contains a further uncharacterized low molecular weight Bax isoform (6 kDa) that is not detectable in the cytosolic fraction.
In the case of Bak (Figure 4d ), the monomer (28 kDa) is almost absent in the cytosolic fraction of the ME-A cells under all cell culture conditions analysed, but there ng of ME-A and ME-C cell MCs, (b) 10 mg of the ME-A and ME-C cell lysates and (c) 20 mg of ME-A cell MC were subjected to 10% SDS-PAGE, transferred onto an Immobilon P membrane and hybridized with a mouse monoclonal antiOPN. Tissue culture conditions are indicated. (d) Twenty micrograms of the ME-C cell MC was subjected to 2D gel electrophoresis and the gel was used for silver staining. (e) For immunoblotting, 1 mg of the ME-C cell MC was applied. The PVDF membrane was incubated with mouse monoclonal anti-OPN and with peroxidase-conjugated goat anti-mouse. The blot was developed by enhanced chemiluminescence, exposure time: 3 s. (f) The marked section of the silver-stained gel (d) showing the 20-40 kDa proteins secreted by the ME-C cells. The small arrows indicate proteins not secreted by the ME-A cell and the large arrow OPN. (g) Twenty micrograms of the ME-A cell MC was subjected to 2D gel electrophoresis and the gel was used for silver staining; the same gel section as in (f) is shown. kDa: protein markers.
Chemotherapy resistance of mouse WAP-SVT/t M Graessmann et al are low amounts of higher molecular weight Bak forms, indicating that oligomerization occurs already in the cytosol. Cross-contamination between the two fractions is very unlikely, as there are Bak variants present in the mitochondrial fraction that are absent in the cytosolic fraction and vice versa. The majority of this proapoptotic protein is present as oligomers in the mitochondrial fraction. Serum withdrawal and dicoumarol caused a slight increase and MC a marginal decrease of the mitochondrial Bak content. The ME-A cells exhibit low gene expression levels of the antiapoptotic proteins Bcl-2 and Bcl-X L (Supplement 1) and in relation to the proapoptotic proteins, the antiapoptotic proteins are clearly under represented. Bcl-2 is predominantly mitochondrial and not detectable in the cytosolic fraction (Figure 4e ). Bcl-X L is found in both cellular fractions, but the mitochondrial lysates contain slightly higher amounts. Serum starvation causes an increase and MC leads to a decline of the mitochondrial Bcl-X L (Figure 4f) .
Furthermore, IAPs are not differentially expressed in the ME-A cells and MC does not enhance the expression level of IAPs and FLIP in serum starved or in doxorubin-treated ME-A cells. The expression profile of caspase-9 and of caspase-3, which is the most abundant effector caspase in ME-A cells, was not altered by MC (Supplement 1).
Apaf-1 increased in doxorubicin-treated cells and its expression was reduced to the original level by the MC (Supplement 3), but growth factor withdrawal did not change the Apaf-1 transcription rate (Supplement 1).
With regard to the effect of growth factor withdrawal and doxorubicin treatment on the level of gene expression, it should be noted that a large number of genes are differentially expressed, exhibiting at least a twofold change of the expression level. In the case of serum withdrawal, the expression level of 877 genes is altered and 341 of them revert to their original expression level by MC. Among them are 33 cell death-associated genes (26 up and 7 down) that are mainly ROS related (Supplement 2). Doxorubicin treatment altered the expression level of 3132 genes, of which 1470 are MC sensitive (Supplement 3).
These studies document the complexity of alterations that occur in the stimulated cells. However, the data obtained do not provide a conclusive indication of how MC prevents ME-A cell apoptosis.
Therefore, we applied different protein kinase inhibitors to obtain a further insight in to the antiapoptotic function of MC. It is well documented that stress activates the JNKs and p38 kinase (Kanda and Miura, 2004) . Depending on the cellular context, JNK activation promotes either cell death or cell survival. In the MCF-7 breast cancer cells, inhibition of apoptosis by the insulin-like growth factor 1 was abrogated by the JNK inhibitor dicoumarol (Krause et al., 2001) . In UVirradiated cells, the activated JNK pathway caused mitochondrial cytochrome c release and cell death (Tournier et al., 2000) . To prove whether the ME-A cell induced apoptosis is JNK directed, dicoumarol (35 mM) was added to the medium of serum-starved ME-A cells and the apoptosis rate was determined 22 h later. As shown in Figure 5 , dicoumarol blocked ME-A cell apoptosis. Dicoumarol also inhibited the doxorubicininduced apoptosis at the level of the non-treated control cells ( Figure 5 ). This demonstrates that JNK activation is the distal death signal for both growth factor depletion and doxorubicin-induced DNA damage. The p38 inhibitor SB202190 (25 mM) had only minor effects on ME-A cell apoptosis rate (data not shown). We further analysed mitochondrial cytochrome c release and found that dicoumarol strongly reduced this release in serum-starved (Figure 4a ) as well as in doxorubicintreated ME-A cells (data not shown). This indicates that Figure 4 Detection of apoptosis relevant proteins by Western blot analysis. Mitochondrial and cytosolic fractions (15 mg) of ME-A cells were subjected to 10% SDS-PAGE and transferred onto a PVDF membrane. The membranes were hybridized with: (a) mouse monoclonal anti-cytochrome c; (b) rabbit polyclonal anti-caspase-9, p35 and p18 are the processed caspase-9 fragments; (c) rabbit polyclonal anti-Bax; (d) rabbit polyclonal anti-Bak; (e) mouse monoclonal anti-Bcl-2; (f) mouse monoclonal anti-Bcl-X L ; and (g) goat polyclonal anti-cytochrome c oxidase III. The ME-A cell culture conditions are indicated above. kDa: protein markers. the antideath function of dicoumarol is distinct from that of OPN-containing ME-C cell medium.
MC blocks a target downstream of caspase-3
In order to consider OPN as the major antiapoptotic factor of the MC its signaling was analysed. OPN is the ligand for CD44 and integrin receptors (a v b 1 , a v b 3 , a v b 5 ) and the corresponding genes are expressed in the ME-A cells (Supplement 1). Therefore, PI3K/Akt as well as MEK1/MEK2 could mediate the inhibitory activity of OPN. The principal role of Akt is to facilitate growth factor-mediated cell survival (Osaki et al., 2004) . Akt activates diverse downstream targets that exert antiapoptotic activity including several transcription factors (e.g. NFkB, AFX, Daf-16, FKHR), it inactivates key players of apoptosis such as Bad and prevents caspase-9 auto processing via phosphorylation. However, the corresponding phosphorylation site is absent at the mouse caspase-9 (Fujita et al., 1999) . To prove whether the MC operates via Akt, the Akt inhibitor (20 mM) was applied to serum-starved ME-A cells, and it slightly increased the apoptosis rate (data not shown). However, regardless of the initial trigger, the Akt inhibitor did not affect the antiapoptotic activity of the MC (e.g. growth factor withdrawal, Figure 5 ).
In contrast, the MEK1/2 inhibitor PD98059 (25 mM) profoundly affected the ME-A cell apoptosis rate. When added to the ME-A cells under standard culture conditions, the cell death rate increased and the apoptotic effect of serum starvation as well as doxorubicin was significantly augmented (Figure 5 ). In addition, PD98059 considerably inhibited the antiapoptotic activity of the MC (Figure 5 ). This demonstrates that OPN activates the MEK/ERK pathway that is known to have the capability to inhibit apoptosis in several cell types, downstream of mitochondrial injury via activation of inhibitors of apoptosis such as X-linked inhibitor of apoptosis (XIAP), which binds to and inhibits caspase-9 as well as the effector caspase-3 and caspase-7 (Erhardt et al., 1999; Gardai et al., 2004; Hu et al., 2004) .
Therefore, we analysed the status of caspase-9 and caspase-3 in ME-A cells. Autoprocessing of caspase-9 occurs in the context of apoptosomes, which significantly increases caspase-9 activity. The unprocessed procaspase-9 has a molecular weight of about 45 kDa and the large fragment of the processed caspase-9 of 35 kDa, which is the functional unit and about 10-fold more active than the procaspase (Srinivasula et al., 1998; Johnson and Jarvis, 2004) . To prove whether the OPN containing MC prevents caspase-9 progression, cytoplasmic and mitochondrial fractions were subjected to Western blot analysis. As shown in Figure 4b , the major portion of the cytoplasmic caspase-9 was processed in the ME-A cells cultivated under standard conditions and serum withdrawal did not augment caspase-9 processing. The same cleavage pattern was demonstrable in the presence of MC. Only dicoumarol reduced caspase-9 processing as well as cytochrome c release (Figure 4a and b) . Similar results were obtained with doxorubicin-treated cells (data not shown). The mitochondrial fraction contained only trace amounts of processed caspase-9. Mitochondrial accumulation of processed caspase-9 was demonstrated elsewhere (Costantini et al., 2002) .
Therefore, caspase-9 is not the downstream target of MC. Utilizing the caspase-3-specific CaspACE Assay system (Talanian et al., 1997) , we determined the caspase-3 activity in the corresponding cell extracts. As summarized in Figure 6 , caspase-3 activity increased about 4-5-fold upon serum starvation. The activity was normalized in the ME-A cells by MC treatment and reduced by dicoumarol. These results indicate that in growth factor starved-ME-A cells, MC signaling prevents caspase-3 activation and the IAPs are possible downstream targets of MC. However, this is not the case when ME-A cell apoptosis is induced by doxorubicin. apoptosis rate (%) starvation doxorubicin Figure 5 The effect of protein kinase inhibitors on the ME-A cell apoptosis. Apoptosis was induced by either serum starvation or doxorubicin in the presence of different protein kinase inhibitors. The following inhibitors were applied for 22 h: JNK inhibitor dicoumarol (35 mM); MEK1/MEK2 inhibitor PD98059 (50 mM); Akt inhibitor (20 mM).
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Doxorubicin increased the caspase-3 activity about sixfold, but in contrast to growth factor depletion, neither MC nor dicoumarol inhibited the caspase-3 activity ( Figure 6 ) although apoptosis was blocked (Figures 1i and Figure 5 ). Therefore, ME-A cells contain an uncharacterized factor(s), which operates downstream of caspase-3 that is inhibited by MC in doxorubicin-treated cells. The results obtained in this investigation strongly support the working hypothesis that OPN signals cell survival and hence therapy resistance, as is outlined in Figure 7 . Of further significance is the observation that therapy resistance can be mediated by a small number of tumor cells, which secrete OPN in large quantities to surrounding tumor cells, which are otherwise chemotherapy sensitive. In our mouse breast cancer model, the OPN-secreting tumor cells carry a p53 missense mutation that also occurs frequently in human breast cancer cells. So far, we have not addressed the question whether the functional loss of p53 in the ME-C cells is sufficient for OPN overexpression. The OPN gene has a p53-response element in its promoter region. It has been reported that in mouse and rat fibroblasts, p53 causes OPN gene activation (Morimoto et al., 2002) and not inhibition, as implicated by our results. This indicates that, depending on the cellular context, p53 either activates or suppresses OPN gene expression. Western blot analysis revealed that the ME-C cells secrete multiple OPN isoforms, which most likely represent post-translational modifications. However, our experiments demonstrated further that only the lower size OPN forms (20-40 kDa) are connected with the antiapoptotic activity. The lager OPN molecules did not prevent ME-A cell apoptosis. The active OPN forms were neither present in highly enriched ME-A cell MC nor in the recombinant OPN, synthesized in mouse myeloma cells (data not shown). This indicates that cell type-specific post-translational modifications such as glycosylation or site-specific phosphorylation may determine the antiapoptotic activity of the secreted OPN.
Experimental procedures

Cell culture
The ME-A and ME-C cells (Tzeng et al., 1998) were plated at 1 Â 10 5 cells/ml and cultured under standard conditions (5% CO 2 , 371C) in DMEM supplemented with 5% FCS (Invitrogen, Karlsruhe, Germany). Apoptosis was induced by serum withdrawal (0% FCS, DMEM) or by treating the cells with medium plus 5% FCS containing 1 mM doxorubicin (Sigma, Taufkirchen, Germany) for 22 h at day 2 after plating. Apoptotic cells were identified by propidium iodide staining 2 mg/ml for 10 min (Sigma), and counted under the fluorescence microscope (Zeiss, Axioskop). The following inhibitors were applied for 22 h: JNK inhibitor dicoumarol (35 mM, Calbiochem, Schwalbach/Ts, Germany); MEK1/MEK2 inhibitor PD98059 (50 mM, Calbiochem); Akt inhibitor (20 mM, Calbiochem), p38 MAPK inhibitor SB202190 (25 mM, Calbiochem).
Preparation of the ME-A and ME-C cell medium concentrates ME-A and ME-C cells were plated at 1 Â 10 5 cells/ml and grown for 2 days under standard culture conditions and further cultivated in DMEM without serum (0% FCS) for 48 h.
The medium was collected, centrifuged at 1900 g for 30 min, the supernatant was dialysed against 0.1 Â PBS at 41C and concentrated under vacuum to 1/10 of the original volume. The protein content was determined using the Bradford protein assay (Bio-Rad, Hercules, CA, USA) and the final protein concentration was adjusted to 500 mg/ml PBS.
OPN depletion in the ME-C cell medium concentrate For OPN depletion, the ME-C cell medium concentrate (protein concentration: 5 mg/ml) was repeatedly treated serum starvation inhibition of apoptosis or doxorubicin Figure 7 Diagram of ME-A cell apoptosis and inhibition by OPN. Serum starvation as well as DNA damage (e.g. doxorubicin treatment) causes JNK activation, mitochondrial cytochrome c (cyto c) release and ME-A cell apoptosis (red). Dicoumarol inhibits JNK and prevents apoptosis (blue). The antiapoptotic effect of OPN is mediated by MEK1/2 (green). In serum-starved ME-A cells, MEK1/2 mediates caspase-3 inhibition and in DNA damaged cells, inhibition of apoptosis occurs downstream of caspase-3. The MEK1/2 inhibitor PD98059 restores apoptosis induced by serum starvation or doxorubicin (blue).
with either mouse monoclonal anti-OPN (Santa Cruz, sc-21742) or goat polyclonal anti-OPN (R&D Systems, Weisbaden, Germany, AF808) and Protein G Plus Agarose (Santa Cruz, Santa Cruz, CA, USA, sc-2002) . The supernatant obtained after the fourth successive immunoprecipitation step was used for the apoptosis inhibitory studies.
RNA preparation and microarray analysis RNA was isolated from 2 Â 10 7 ME-A and ME-C cells cultivated under standard conditions, under starvation (0% FCS) or doxorubicin in the presence or absence of MC. Total RNA was extracted with 2 ml RNAzol reagent in accordance to the manufacturer instructions (PeQLab Biotechnology, Erlangen, Germany). Hundred micrograms of the isolated RNA was treated with 2 U RNase-free DNase (DNA-free, Ambion, Huntingdon, Cambridgeshire, UK). The integrity of RNA was verified using the Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA), by the presence of the 28S and 18S rRNA on agarose gels and an A 260 / 280 ratio in the range of 1.9-2.1. For microarray analysis 7 mg of total RNA were used for production of biotinylated cRNA as described in the Affymetrix GeneChip analysis instruction manual (Affymetrix). In short, RNA was converted into cDNA using T7-oligo (dT) primer followed by the synthesis of double-stranded DNA utilizing the SuperScript double-stranded cDNA synthesis kit (Invitrogen). The double-stranded DNA was transcribed in vitro into biotinylated cRNA (RNA Transcript labeling Kit, Enzo Life Sciences, Farmingdale, NY, USA) and the synthesized cRNA was fragmented in RNA fragmentation buffer (200 mM Tris-acetate, pH 8.2, 500 mM KOAc, 150 mM MgOAc) at 941C for 35 min. The Affymetrix GeneChip Mouse Expression Set 430A 2.0 was then hybridized with the biotin-labeled cRNA for 16 h at 451C. Washing steps for the chip, staining with streptavidin-phycoerythrin, and signal amplification were performed according to the manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). Each hybridized Affymetrix GeneChip array was scanned with GeneChip Scanner 3000. The raw experimental microarray data were normalized with the Affymetrix GeneChip Operating Software (GCOS) based on the housekeeping gene method. Expression values obtained were adjusted to the intensity of the corresponding expression value of 100 housekeeping genes. Transcripts with average signal values lower than the minimum threshold of 50 arbitrary units were excluded (Klein et al., 2005) .
Our CorrXpression software was used to identify differentially expressed genes (Wessel et al., 2006;  (www.charite.de/molbiol/bioinf/tumbiol/). Upregulation and downregulation were defined whenever each expression value was higher or lower by factor 2.
Protein extraction and Western blot
For Western blot analysis, the proteins were extracted from enriched mitochondrial and cytosolic fraction. For effective isolation of highly enriched mitochondrial and cytosolic fractions the Cytosol/Mitochondria Fractionation Kit (Oncogene) was used and isolation was performed according to the manufacturer's instructions. Fifteen micrograms of each cytosolic or mitochondrial protein lysates was subjected to 10% sodium dodecyl sulphate (SDS)-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto an Immobilon P membrane (PVDF, Millipore, Billerica, MA, USA). The membranes were hybridized with mouse monoclonal anti-cytochrome c (BD PharMingen, San Diego, CA, USA, 556433), goat polyclonal anticytochrome c oxidase III (Santa Cruz sc-23986), mouse monoclonal anti-OPN (Santa Cruz, sc-21742), rabbit polyclonal anti-caspase-9 (Stressgen, Ann Arbor, MI, USA, AAP-149), rabbit polyclonal anti-Bak (Santa Cruz, sc-832), rabbit polyclonal anti-Bax (Santa Cruz, sc-6236), mouse monoclonal anti-Bcl-2 (Santa Cruz, sc-7382) or mouse monoclonal anti-Bcl-X L (Santa Cruz, sc-8392). Blots were then incubated with anti-mouse-horse radish peroxidase (HRP), anti-rabbit-HRP or anti-goat-HRP (Dako Diagnostika GmbH, Hamburg, Germany) and developed using a chemiluminescence detection system (Perkin Elmer Life Science, Rodgau-Jugesheim, Germany).
Total cell lysates were prepared from ME-C and ME-A cells in lysis buffer (50 mM Tris-HCl, pH 7.8, 150 mM NaCl, 2.5 mM ethylenediaminetetraacetic acid (EDTA), 1% NP40, 1 mM phenylmethylsulfonyl fluoride (PMSF) and 1 mg/ml of each of the protease inhibitors pepstatin, aprotinin and leupeptin).
Caspase-3 (CPP32) activity assay CPP32 activity was determined with the CaspACE Colorimetric Assay System (Promega, Mannheim, Germany) according to the manufacturer's instructions. After incubation under standard conditions, serum withdrawal with or without MC, doxorubicin (1 mM) with or without MC, as well as with the inhibitor dicoumarol (35 mM) the apoptotic cells were collected. After centrifugation for 10 min at 450 g, the cells were washed with PBS and the cell pellets were lysed with 100 mg of lysis buffer provided with the kit. A 100 mg portion of the protein extracts was incubated with Ac-DEVD-p-nitroanilide (pNA) for 4 h at 371C, and the chromophore pNA was measured spectrophotometrically at 405 nm.
Two-dimensional electrophoresis Two-dimensional electrophoresis was performed as described elsewhere (Caudevilla et al., 2001) . In short, each 18 cm isoelectric focusing (IEF) gel strip with a nonlinear pH gradient of 3-10 (Pharmacia, Wein, Austria) was loaded with 1 mg of ME-C cells or 10 mg of ME-A cells MC, dissolved in 0.3 ml 1.0 Â IEF buffer (7.4 M urea, 2 M thiourea, 2% CHAPS, 1% immobiline buffer, pH 3-10, 1% dithiothreitol (DTT), 1% bromophenol blue) and allowed to rehydrate overnight at 201C. IEF was carried out on a Pharmacia Multiphor cell, starting at 300 V for 10 min, followed by 500 V for 5 h and then at a constant voltage of 3500 V for 14.5 h.
After IEF, the gel strip was incubated in equilibration buffer (50 mM Tris-HCl, pH 8.8, 6 M urea, 30% glycerol, 2% SDS, 100 mM DTT) for 15 min at room temperature and then for 15 min in the same buffer without DTT but containing 400 mM iodacetamide. The gel strip was then placed onto a 10% SDS-polyacrylamide gel, which was run at 8 mA overnight in a Bio-Rad electrophoresis chamber. The proteins were then blotted onto an Immobilon P membrane at 1 mA/cm 2 for 90 min using a semi-dry cell. The membrane was incubated with mouse monoclonal anti-OPN (Santa Cruz, sc-21742). After incubation with the peroxidase-conjugated secondary antibody, the blot was developed by enhanced chemiluminescence (Perkin-Elmer Life Science).
For silver nitrate staining of the gel, 20 mg of ME-A or ME-C cell MCs was loaded on the IEF gel strip and electrophoresis was performed as described above. The silver nitrate staining was performed as described elsewhere (Shevchenko et al., 1996) with slight modifications. In short, the gel was fixed in 40% methanol and 10% acetic acid over night, washed twice in 30% ethanol for 20 min each and three times with water for 30 min each. The gel was then sensitized by incubation in 0.02% Na 2 S 2 O 3 for 1 min and after three washes with water for 20 s each, impregnated with 0.15% AgNO 3 for 20 min at 41C. For image development, the gel was incubated in develop solution containing 2% Na 2 CO 3 , 0.04% HCHO and 0.0005% Na 2 S 2 O 3 for 7 min. The reaction was stopped with 0.5% glycine for 30 min.
